Single Use Cannula V PR-V220QRecalls & reported problems

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04953170183614), received between Jan 6, 2023 and Jan 9, 2023 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

• InjuryJan 9, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED, "BALLOON ENTEROSCOPY-ASSISTED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FOR THE TREATMENT OF COMMON BILE DUCT STONES IN PATIENTS WITH ROUX-EN-Y GASTRECTOMY: OUTCOMES AND FACTORS AFFECTING COMPLETE STONE EXTRACTION." THIS RETROSPECTIVE STUDY INVESTIGATED THE TREATMENT OUTCOMES AND POTENTIAL FACTORS AFFECTING COMPLETE STONE EXTRACTION IN 79 PATIENTS. THE INITIAL SUCCESS RATES OF REACHING THE PAPILLA OF VATER, BILIARY CANNULATION, AND BILIARY INTERVENTION, INCLUDING COMPLETE STONE EXTRACTION OR BILIARY STENT PLACEMENT, WERE 92%, 81%, AND 78%, RESPECTIVELY. THE MULTIVARIATE ANALYSIS INDICATED THAT THE LARGEST CBD DIAMETER = 14 MM (ODDS RATIO (OR), 0.04; 95% CONFIDENCE INTERVAL (CI), 0.01¿0.58) AND RETROFLEX POSITION (OR, 6.43; 95% CI, 1.12¿36.81) WERE INDEPENDENT PREDICTIVE FACTORS AFFECTING COMPLETE STONE EXTRACTION ACHIEVEMENT. THIS STUDY CONCLUDES THAT THERAPEUTIC SDBE-ERCP FOR CBD STONES IN A RELATIVELY ELDERLY RYG COHORT, WAS EFFECTIVE AND SAFE. TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS MILD PERFORATION - 1 PATIENT MODERATE PERFORATION - 1 PATIENT MILD PANCREATITIS - 1 PATIENT MILD HYPOXIA - 1 PATIENT THIS WAS A MULTI-CENTER R

  Patient problems: Hypoxia; Pancreatitis; Perforation

  MAUDE report 16126459 ↗
• InjuryJan 6, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED, "BALLOON ENTEROSCOPY-ASSISTED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY FOR THE TREATMENT OF COMMON BILE DUCT STONES IN PATIENTS WITH ROUX-EN-Y GASTRECTOMY: OUTCOMES AND FACTORS AFFECTING COMPLETE STONE EXTRACTION." THIS RETROSPECTIVE STUDY INVESTIGATED THE TREATMENT OUTCOMES AND POTENTIAL FACTORS AFFECTING COMPLETE STONE EXTRACTION IN 79 PATIENTS. THE INITIAL SUCCESS RATES OF REACHING THE PAPILLA OF VATER, BILIARY CANNULATION, AND BILIARY INTERVENTION, INCLUDING COMPLETE STONE EXTRACTION OR BILIARY STENT PLACEMENT, WERE 92%, 81%, AND 78%, RESPECTIVELY. THE MULTIVARIATE ANALYSIS INDICATED THAT THE LARGEST CBD DIAMETER = 14 MM (ODDS RATIO (OR), 0.04; 95% CONFIDENCE INTERVAL (CI), 0.01¿0.58) AND RETROFLEX POSITION (OR, 6.43; 95% CI, 1.12¿36.81) WERE INDEPENDENT PREDICTIVE FACTORS AFFECTING COMPLETE STONE EXTRACTION ACHIEVEMENT. THIS STUDY CONCLUDES THAT THERAPEUTIC SDBE-ERCP FOR CBD STONES IN A RELATIVELY ELDERLY RYG COHORT, WAS EFFECTIVE AND SAFE. TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS MILD PERFORATION - 1 PATIENT MODERATE PERFORATION - 1 PATIENT MILD PANCREATITIS - 1 PATIENT MILD HYPOXIA - 1 PATIENT THIS WAS A MULTI-CENTER R

  Patient problems: Hypoxia; Pancreatitis; Perforation

  MAUDE report 16117455 ↗